Medical biotechnology is an application of biotechnology that improves the lives of individuals every day. In the medical biotechnology research group, we use state-of-the-art technologies to obtain knowledge applicable in the development of better diagnostics and therapeutics. In addition, we seek knowledge of fundamental biological systems, allowing a better differentiation between disease and normal human development and health.
- Ageing and age related diseases
- Cancer and circulating tumor cells
- Cardiovascular and heart diseases
- Probiotics and microbiota
- Antibody technology
- Proteases and disease
- Pathological calcium signaling
- Bioactive peptides and secondary metabolites
- Novel lead compounds for drug development
Our research is driven by the ambition of applying science to understand, prevent and treat human diseases.
Within the area of medical biotechnology we collaborate broadly with local and national institutions and experts. These include, but are not limited to, researchers from Faculty of Medicine, AAU and Aalborg University Hospital, Copenhagen University, Herlev Hospital, Danish Technical University, and Aarhus University. Internationally we collaborate with researchers all over the world including Japan, China, Australia, Europe and US.
Applied supramolecual chemistry
Chemical process engineering
Environmental chemical engineering
Environmental bioscience and biomonitoring
Biodiversity and evolutionary biology
Ageing and age related diseases, probiotics and microbiota, proteomics and metabolomics, stress responses and apoptosis and molecular motors
Cancer and circulating tumor cells, ageing and age related diseases, antibody technology and molecular engineering.
Biological NMR spectroscopy, cardiovascular and heart diseases, bioactive peptides and secondary metabolites, metabolomics and protein-ligand interactions.
Cardiovascular and heart disease, brown Bear as a translational model, proteases and disease, valorization of industrial protein side streams.
Advancing green biorefining from the bottom-up: From grass to food protein and ingredients aided by proteomics and bioinformatics
Published / Submitted 2022
Simon Gregersen Echers, Tuve Mattsson, Mads Koustrup Jørgensen, Emil Gundersen, Stefan Ulrich Heiske, Christian Holt, Morten Olsen, Peter Stephensen Lübeck, Mette Lübeck
To be updated
A selection of our business partners:
- Novo Nordisk
- Associate Professor Anders Olsen
- PhD student Maria Grymer Metz Mørch
- PhD student Katrine Christensen
- PhD student Rikke Hindsgaul Harders
- Msc student Therese Buhl
- MSc student Lam Thùy Lê
- MSc student Caroline Lund Kidmose
- Professor Michael Toft Overgaard
- Postdoc Simon Gregersen
- Postdoc Malene Brohus
- Postdoc Helene Halkjær
- PhD student Anne Mette Frøbert
- Associate Professor Peter Kristensen
- Postdoc Aida Droce
- MSc student Irene Delgado Alonso
- MSc Student Lærke Andersen
- MSc student Emilie Kjærsgaard
- Student helper Emil Juel Zeuner
Natural product chemistry
Medical microbiology and biotechnology